Literature DB >> 7541136

Oligonucleotide N3'-->P5' phosphoramidates.

S M Gryaznov1, D H Lloyd, J K Chen, R G Schultz, L A DeDionisio, L Ratmeyer, W D Wilson.   

Abstract

Synthetic oligonucleotides and their analogs have attracted considerable interest recently. These compounds may lead to highly specific therapeutic agents, as well as to powerful diagnostic tools. Here, we present the synthesis of uniformly modified oligodeoxyribonucleotide N3'-->P5' phosphoramidates containing 3'-NHP(O)(O-)O-5' internucleoside linkages and the study of their hybridization properties. Thermal dissociation experiments show that these compounds form very stable duplexes with single-stranded DNA, RNA, and with themselves following Watson-Crick base pairing. The duplex thermal stability was enhanced by 2.2-2.6 degrees C per modified linkage compared with phosphodiesters. The structure of complexes formed by phosphoramidates closely resembles that of RNA oligomers and corresponds to an A form, as judged by CD spectroscopy. N3'-->P5' phosphoramidates also form stable triplexes with double-stranded DNA under near-physiological conditions when natural phosphodiesters fail to do so. Physicochemical characteristics of the amidates are similar to those of RNA oligomers, even though they are composed of 2'-deoxyfuranose-based nucleosides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541136      PMCID: PMC41588          DOI: 10.1073/pnas.92.13.5798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

Review 1.  Oligonucleoside methylphosphonates as antisense reagents.

Authors:  P S Miller
Journal:  Biotechnology (N Y)       Date:  1991-04

2.  Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition.

Authors:  R W Roberts; D M Crothers
Journal:  Science       Date:  1992-11-27       Impact factor: 47.728

Review 3.  Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material.

Authors:  C Zimmer; U Wähnert
Journal:  Prog Biophys Mol Biol       Date:  1986       Impact factor: 3.667

4.  Sequence-specific recognition of double helical RNA and RNA.DNA by triple helix formation.

Authors:  H Han; P B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Gene synthesis machines: DNA chemistry and its uses.

Authors:  M H Caruthers
Journal:  Science       Date:  1985-10-18       Impact factor: 47.728

6.  Synthesis and properties of oligonucleotides containing aminodeoxythymidine units.

Authors:  S M Gryaznov; R L Letsinger
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

Review 7.  Phosphorodithioate DNA as a potential therapeutic drug.

Authors:  W S Marshall; M H Caruthers
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

8.  Thermodynamics of DNA duplexes with adjacent G.A mismatches.

Authors:  Y Li; G Zon; W D Wilson
Journal:  Biochemistry       Date:  1991-07-30       Impact factor: 3.162

9.  Oligoaminonucleoside phosphoramidates. Oligomerization of dimers of 3'-amino-3'-deoxy-nucleotides (GC and CG) in aqueous solution.

Authors:  W S Zielinski; L E Orgel
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

10.  Importance of oligoelectrolyte end effects for the thermodynamics of conformational transitions of nucleic acid oligomers: a grand canonical Monte Carlo analysis.

Authors:  M C Olmsted; C F Anderson; M T Record
Journal:  Biopolymers       Date:  1991-11       Impact factor: 2.505

View more
  38 in total

1.  Inhibition of IL-6 in mice by anti-NF-kappaB oligodeoxyribonucleotide N3'-->oligodeoxyribonnucleotide N3' --> P5' phosphoramidates.

Authors:  L Wang; S Gryaznov; M Nerenberg
Journal:  Inflammation       Date:  1999-12       Impact factor: 4.092

2.  Solution structure of a DNA duplex with a chiral alkyl phosphonate moiety.

Authors:  R Soliva; V Monaco; I Gómez-Pinto; N J Meeuwenoord; G A Marel; J H Boom; C González; M Orozco
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

3.  Altered structural fluctuations in duplex RNA versus DNA: a conformational switch involving base pair opening.

Authors:  Yongping Pan; Alexander D MacKerell
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

Review 4.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

5.  Crystal structures of B-DNA with incorporated 2'-deoxy-2'-fluoro-arabino-furanosyl thymines: implications of conformational preorganization for duplex stability.

Authors:  I Berger; V Tereshko; H Ikeda; V E Marquez; M Egli
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

6.  Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.

Authors:  R G Schultz; S M Gryaznov
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

7.  Stabilization of triple-stranded oligonucleotide complexes: use of probes containing alternating phosphodiester and stereo-uniform cationic phosphoramidate linkages.

Authors:  S Chaturvedi; T Horn; R L Letsinger
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

8.  Hydration effects on the duplex stability of phosphoramidate DNA-RNA oligomers.

Authors:  D Barsky; M E Colvin; G Zon; S M Gryaznov
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

Review 9.  Crystallographic studies of chemically modified nucleic acids: a backward glance.

Authors:  Martin Egli; Pradeep S Pallan
Journal:  Chem Biodivers       Date:  2010-01       Impact factor: 2.408

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.